2016 American Transplant Congress

June 11-15, 2016 in Boston, MA

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Identification of MicroRNAs in EBV⁺ B Cell Lymphomas and Secreted Exosomes.

V. Kaul, A. Harris-Arnold, C. Esquivel, O. Martinez, S. Krams.
Identifying Social Barriers to Health Literacy in ESRD Patients Undergoing Kidney Transplant Evaluation.

K. Leick,¹ J. Jones,¹ S. Witte,² L. Hunsicker,³ Z. Stewart.¹
IFN-γ and Contact-Dependent Cytotoxicity Are Rate-Limiting for NK Cells in a Model of Antibody-Mediated Chronic Rejection.

C. Lin,¹ R. Plenter,¹ R. Gill.²
IFTA Is Linked to Urinary Microbiome Changes.

B. Modena, R. Milam, F. Harrison, S. Kurian, D. Salomon, A. Kirk.
IgG Dilutions, Subclasses, C1q, and IgM: Determining Relevant Testing for De Novo DSA and Outcome Prediction.

M. Everly,¹ L. Rebellato,² C. Haisch,² K. Briley,² P. Bolin,² S. Kendrick,³ C. Morgan,² A. Maldonado,⁴ A. Nguyen,¹ P. Terasaki.¹
IgM Donor Specific Antibodies Are Frequently Associated with C1q-binding DnDSA in Renal Transplant Recipients.

J. Bamoulid,³ A. Roodenburg,⁴ O. Staeck,¹ C. Schoenemann,² N. Lachmann,² K. Budde.¹
IgM Treatment Successfully Prevents Type 1 Diabetes by Dysregulation of Pancreatic MicroRNAs with Immunomodulatory Roles.

P. Chhabra, R. Gehrau, V. Mas, D. Bower, D. Maluf, K. Brayman.
IL-10 Expression of In Vitro Activated B Cells as A Biomarker for B Cell Tolerance.

T. Oura, K. Hotta, K. Crisalli, B. Cosimi, T. Kawai.
IL-17-Producing CCR6⁺CD4⁺ Th17 Cells Drive Intestinal Allograft Rejection in Humans.

J. Kaiser, C. Cosentino, A. Shukla, C. Desai, R. Girlanda, J. Hawksworth, C. Matsumoto, M. Zasloff, T. Fishbein, A. Kroemer.
IL-17A Preactivated Mesenchymal Stem Cells (MSC-17) Are Enriched for Genes Involved in T Cell Chemotaxis to Mediate Superior Immunosuppression.

K. Sivanathan,^1,2,3 D. Rojas-Canales,^1,2 S. Gronthos,⁴ S. Grey,⁵ P. Coates.^1,2,3

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z